ReviewBMC infectious diseases2014
Hepatitis C in European prisons: a call for an evidence-informed response.
Review in BMC infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Hepatitis C prevalence in incarcerated settings between 2013-2021: a systematic review and meta-analysis.BMC public health · 2022Pooled it
- A multicentre interventional study to assess blood-borne viral infections in Belgian prisons.BMC infectious diseases · 2021Trial
- Hepatitis B and hepatitis C virus infections and associated factors among prisoners in Gondar City, Northwest Ethiopia.PloS one · 2024Article
- Is Illicit Substance Use Gender-Specific? The Basic Points of Mental and Health Disorders.Toxics · 2022Review
- The impact of direct-acting antivirals on hepatitis C viraemia among people who inject drugs in England; real-world data 2011-2018.Journal of viral hepatitis · 2021Article
- New hepatitis C virus infection, re-infection and associated risk behaviour in male Irish prisoners: a cohort study, 2019.Archives of public health = Archives belges de sante publique · 2021Article
- More evidence or stronger political will: exploring the feasibility of needle and syringe programs in Ukrainian prisons.Harm reduction journal · 2021Article
- High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing.Harm reduction journal · 2020Article
- Opioid epidemic and liver disease.JHEP reports : innovation in hepatology · 2019Review
- Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners.Harm reduction journal · 2019Observational
- Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration.Health & justice · 2018Article
- Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.Harm reduction journal · 2018Article
- A liver health hui: hepatitis C knowledge and associated risk factors in New Zealand gang members and their families.Royal Society open science · 2018Article
- Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015.BMC infectious diseases · 2018Article
- Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.Harm reduction journal · 2018Article
- High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany.BMC public health · 2017Article
- Risk behaviour determinants among people who inject drugs in Stockholm, Sweden over a 10-year period, from 2002 to 2012.Harm reduction journal · 2017Article
- Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland.Addiction (Abingdon, England) · 2017Article
- Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study.International journal for equity in health · 2017Article
- Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.Lancet (London, England) · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, over 10 million people are held in prisons and other places of detention at any given time. People who inject drugs (PWID) comprise 10-48% of male and 30-60% of female prisoners. The spread of hepatitis C in prisons is clearly driven by injection drug use, with many infected prisoners unaware of their infection status. Risk behaviour for acquisition of hepatitis C via common use of injecting equipment is widespread in many prison settings. In custodial settings, effective and efficient prevention models applied in the community are very rarely implemented. Only approximately 60 out of more than 10,000 prisons worldwide provide needle exchange. Thus, HCV prevention is almost exclusively limited to verbal advice, leaflets and other measures directed to cognitive behavioural change. Although the outcome of HCV antiviral treatment is comparable to non-substance users and substance users out of prison, the uptake for antiviral treatment is extremely low. Based on a literature review to assess the spread of hepatitis C among prisoners and to learn more about the impact for the prison system, recommendations regarding hepatitis C prevention, screening and treatment in prisons have been formulated in this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.